Ladder Bio
Focus: Ladder Bio is a public biotechnology company founded in 2020 that specializes in spiroligomers, a proprietary chemistry platform targeting oncology indications. The company is headquartered in Blue Bell, PA and operates at the pre-revenue or early clinical stage.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Ladder Bio?
AI assessmentLadder Bio is a speculative, platform-stage opportunity suitable only for early-career scientists or specialists willing to accept high technical and commercial risk for potential upside in a novel chemistry space.
Why Work Here
- Early-stage platform play with differentiated chemistry (spiroligomers) that could establish you in an emerging modality before it scales
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Ladder Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.